Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2020Mar2019
   EV/Core EBITDA(x) 21.9219.544.094.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 21.92 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.92
Mar202419.54
Mar20204.09
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 21.92
12.18
Mar2024 19.54
377.75
Mar2020 4.09
-16.19
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹630.0 Cr -1.5% -4.7% -37.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.1% 1.9% -8.5% Stock Analytics
DIVIS LABORATORIES ₹182,810.0 Cr 3.5% 18.2% 15.4% Stock Analytics
CIPLA ₹121,170.0 Cr -2.6% -0.9% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,300.0 Cr -1.3% 0.8% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr 0.2% -3.5% -5.8% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-1.5%

-4.7%

-37.5%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses